Wiesner M - Search Results

1

The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease.

Hovhannisyan Z, Weiss A, Martin A, Wiesner M, Tollefsen S, Yoshida K, Ciszewski C, Curran SA, Murray JA, David CS, Sollid LM, Koning F, Teyton L, Jabri B. Hovhannisyan Z, et al. Among authors: wiesner m. Nature. 2008 Nov 27;456(7221):534-8. doi: 10.1038/nature07524. Nature. 2008. PMID: 19037317 Free PMC article.

2

Design of azidoproline containing gluten peptides to suppress CD4+ T-cell responses associated with celiac disease.

Kapoerchan VV, Wiesner M, Overhand M, van der Marel GA, Koning F, Overkleeft HS. Kapoerchan VV, et al. Among authors: wiesner m. Bioorg Med Chem. 2008 Feb 15;16(4):2053-62. doi: 10.1016/j.bmc.2007.10.091. Epub 2007 Nov 4. Bioorg Med Chem. 2008. PMID: 18037302

3

Large-scale characterization of natural ligands explains the unique gluten-binding properties of HLA-DQ2.

Stepniak D, Wiesner M, de Ru AH, Moustakas AK, Drijfhout JW, Papadopoulos GK, van Veelen PA, Koning F. Stepniak D, et al. Among authors: wiesner m. J Immunol. 2008 Mar 1;180(5):3268-78. doi: 10.4049/jimmunol.180.5.3268. J Immunol. 2008. PMID: 18292551

4

Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule.

Kapoerchan VV, Wiesner M, Hillaert U, Drijfhout JW, Overhand M, Alard P, van der Marel GA, Overkleeft HS, Koning F. Kapoerchan VV, et al. Among authors: wiesner m. Mol Immunol. 2010 Feb;47(5):1091-7. doi: 10.1016/j.molimm.2009.10.036. Epub 2009 Dec 3. Mol Immunol. 2010. PMID: 19962195

5

Dominance of an alternative CLIP sequence in the celiac disease associated HLA-DQ2 molecule.

Wiesner M, Stepniak D, de Ru AH, Moustakis AK, Drijfhout JW, Papadopoulos GK, van Veelen PA, Koning F. Wiesner M, et al. Immunogenetics. 2008 Sep;60(9):551-5. doi: 10.1007/s00251-008-0310-6. Epub 2008 Jun 27. Immunogenetics. 2008. PMID: 18584168 Free PMC article.

6

Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines.

Wiesner M, Zentz C, Hammer MH, Cobbold M, Kern F, Kolb HJ, Hammerschmidt W, Zeidler R, Moosmann A. Wiesner M, et al. Eur J Immunol. 2005 Jul;35(7):2110-21. doi: 10.1002/eji.200425936. Eur J Immunol. 2005. PMID: 15971271 Free article.

7

Activated B cells mediate efficient expansion of rare antigen-specific T cells.

Zentz C, Wiesner M, Man S, Frankenberger B, Wollenberg B, Hillemanns P, Zeidler R, Hammerschmidt W, Moosmann A. Zentz C, et al. Among authors: wiesner m. Hum Immunol. 2007 Feb;68(2):75-85. doi: 10.1016/j.humimm.2006.12.004. Epub 2007 Jan 8. Hum Immunol. 2007. PMID: 17321896

8

Conditional immortalization of human B cells by CD40 ligation.

Wiesner M, Zentz C, Mayr C, Wimmer R, Hammerschmidt W, Zeidler R, Moosmann A. Wiesner M, et al. PLoS One. 2008 Jan 23;3(1):e1464. doi: 10.1371/journal.pone.0001464. PLoS One. 2008. PMID: 18213373 Free PMC article.

9

A Diverse Repertoire of CD4 T Cells Targets the Immediate-Early 1 Protein of Human Cytomegalovirus.

Ameres S, Liang X, Wiesner M, Mautner J, Moosmann A. Ameres S, et al. Among authors: wiesner m. Front Immunol. 2015 Nov 25;6:598. doi: 10.3389/fimmu.2015.00598. eCollection 2015. Front Immunol. 2015. PMID: 26635812 Free PMC article.

10

Leveraging nanoparticle environmental health and safety research in the study of micro- and nano-plastics.

Auffan M, Lowry GV, Amos JD, Bossa N, Wiesner MR. Auffan M, et al. Among authors: wiesner mr. NanoImpact. 2024 Nov 17;36:100534. doi: 10.1016/j.impact.2024.100534. Online ahead of print. NanoImpact. 2024. PMID: 39551431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters